# Blood for Immune Response to Provenge® in HRPC

> **NCT01274572** · — · WITHDRAWN · sponsor: **Mary Crowley Medical Research Center**

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01274572
- **Lead sponsor:** Mary Crowley Medical Research Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-01
- **Primary completion:** 2011-01
- **Final completion:** 2011-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Drug became available with insurance reimbursement
- **Last updated:** 2015-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01274572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01274572, "Blood for Immune Response to Provenge® in HRPC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01274572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*